The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | L | Antineoplastic and immunomodulating agents | |
| 2 | L01 | Antineoplastic agents | |
| 3 | L01F | Monoclonal antibodies and antibody drug conjugates | |
| 4 | L01FB | CD22 (Clusters of Differentiation 22) inhibitors | |
| 5 | L01FB02 | Moxetumomab pasudotox |
| Title | Information Source | Document Type | |
|---|---|---|---|
| LUMOXITI Powder for concentrate solution for solution for infusion | European Medicines Agency (EU) | MPI, EU: SmPC | |
| LUMOXITI Powder for solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.
